Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Cancer Science|March 25, 2025
CNDP1 Overexpression by Promoter Hypomethylation Predicts Poor Prognosis and Immunotherapy Response in Mucosal MelanomaJia Jia, Junjie Gu, Lina Gao, et al.
The Journal of Biological Chemistry|May 17, 2019
Stk40 deletion elevates c-JUN protein level and impairs mesoderm differentiationJing Hu, Shuang Li, Xiaozhi Sun, et al.
Scientific Reports|October 28, 2017
Steroid hormone profiling in obese and nonobese women with polycystic ovary syndromeYuying Deng, Yifei Zhang, Shengxian Li, et al.
Oncotarget|December 8, 2016
Early pathogenic event of Alzheimer's disease documented in iPSCs from patients with PSEN1 mutationsJuan Yang, Hanzhi Zhao, Yu Ma, et al.
Communications Biology|November 1, 2023
A new method for examining the co-occurrence network of fossil assemblagesShilong Guo, Wang Ma, Yunyu Tang, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
Stk40 links the pluripotency factor Oct4 to the Erk/MAPK pathway and controls extraembryonic endoderm differentiationLingjie Li, Lei Sun, Furong Gao, et al.
American Journal of Translational Research|September 15, 2022
A clinical trial for computed tomography myocardial perfusion based non-invasive index of microcirculatory resistance (MPBIMR): rationale and trial designBeibei Gao, Darong Zhu, Jianchang Xie, et al.
Cancer Management and Research|May 7, 2025
Real-World Efficacy and Safety of Anti-PD-1 Antibody Plus Apatinib and Temozolomide for Advanced Acral MelanomaJiaran Zhang, Huichun Tian, Lili Mao, et al.
Clinical and Translational Medicine|January 6, 2025
Atezolizumab plus bevacizumab in patients with unresectable or metastatic mucosal melanoma: 3-year survival update and multi-omics analysisJie Dai, Tianxiao Xu, Lifeng Li, et al.
Nature Communications|March 13, 2026
Endogenous VEGF signaling acts as a guardian of human primed pluripotencyXu Wu, Chunsheng Wen, Chaonan Zhu, et al.
Pageof 11